Outcomes of Deferring Percutaneous Coronary Intervention Without Physiologic Assessment for Intermediate Coronary

Jihoon Kim1, Seong-Hoon Lim2, Joo-Yong Hahn3

  • 1Division of Cardiology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

Korean Circulation Journal
|February 18, 2025
PubMed

Insights

Deferring percutaneous coronary intervention (PCI) for intermediate coronary lesions without physiologic assessment led to more major adverse cardiac events (MACE) at 3 years. Medical therapy alone increased revascularization needs compared to PCI.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Clinical Trials

Background:

  • Outcomes of deferring percutaneous coronary intervention (PCI) for intermediate coronary lesions without invasive physiologic assessment remain uncertain.
  • Intermediate coronary lesions are defined as 50-70% diameter stenosis by angiography.

Purpose of the Study:

  • To compare long-term outcomes between medical treatment and PCI for intermediate coronary lesions without invasive physiologic assessment.
  • To evaluate the risk of major adverse cardiac events (MACE) in patients managed conservatively versus those undergoing PCI.

Main Methods:

  • A randomized trial involving 899 patients with intermediate coronary lesions.
  • Patients were assigned to a conservative group (deferred PCI) or an aggressive group (PCI performed).
  • The primary endpoint was MACE (all-cause death, myocardial infarction, or ischemia-driven revascularization) at 3 years.

Main Results:

  • The conservative group had a significantly higher incidence of MACE at 3 years compared to the aggressive group (13.8% vs. 9.3%, p=0.049).
  • This difference was primarily driven by increased target intermediate lesion revascularization in the conservative group (6.5% vs. 1.1%, p<0.001).
  • The conservative group also showed a higher incidence of cardiac death or MI and ischemia-driven revascularization between 1 and 3 years.

Conclusions:

  • Medical therapy alone for intermediate coronary lesions, guided solely by angiography, is associated with a higher risk of MACE at 3 years.
  • Performing PCI for intermediate lesions resulted in fewer MACE, mainly due to reduced revascularization needs.
  • Invasive physiologic assessment may be crucial for guiding treatment decisions in intermediate coronary lesions.
Abstract

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
452
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
502
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
528
Angina II: Classification01:27

Angina II: Classification

Angina, also known as angina pectoris, is a chest pain resulting from diminished blood flow to the heart muscle and is often a symptom of coronary artery disease. Angina presents several variants with distinctive attributes, etiologies, and therapeutic approaches. The main types of angina include stable, unstable, variant (Prinzmetal's), microvascular, intractable, and silent ischemia.Stable angina is caused by atherosclerosis, which leads to the formation of plaques that narrow the coronary...
714
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
496
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
659